Atossa Therapeutics CFO Greg Weaver resigns; Heather Rees appointed as principal financial officer

ATOSSA THERAPEUTICS, INC.

Greg Weaver resigned as EVP and CFO effective Oct 5, 2023; resignation not due to disagreement with company.
Company waived 30-day notice period, accelerating departure to Oct 5.
Heather Rees, previously VP Finance and Accounting, appointed as principal financial and accounting officer.
Rees has been with company since 2017 as controller, then VP; prior experience includes Deloitte and independent consulting.
Weaver's termination also served as resignation from Board of Directors.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Greg Weaver

Executive Vice President and Chief Financial Officer

ATOS · ATOSSA THERAPEUTICS, INC.

Effective: 2023-10-05
Successor: Heather Rees
Filed: October 6, 2023, 7:59 PM ET

Mr. Weaver tendered his resignation to pursue other opportunities and not due to any disagreement with the Company.

Appointed

Heather Rees

principal financial and accounting officer

ATOS · ATOSSA THERAPEUTICS, INC.

Effective: 2023-10-05
Filed: October 6, 2023, 7:59 PM ET

In connection with Mr. Weaver’s resignation, the Company has appointed Heather Rees, age 51, as the Company’s principal financial and accounting officer.

Departed

Greg Weaver

member of the Board of Directors

ATOS · ATOSSA THERAPEUTICS, INC.

Effective: 2023-10-05
Filed: October 6, 2023, 7:59 PM ET

Mr. Weaver’s termination of service as an employee served as his resignation from all other positions with the Company, including as a member of the Board of Directors.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Greg Weaver resigned as Executive Vice President and Chief Financial Officer at ATOSSA THERAPEUTICS, INC..

Action: resigned
Role: Executive Vice President and Chief Financial Officer

Exact text from the filing

Mr. Weaver tendered his resignation to pursue other opportunities and not due to any disagreement with the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Heather Rees was appointed as principal financial and accounting officer at ATOSSA THERAPEUTICS, INC..

Action: appointed
Role: principal financial and accounting officer

Exact text from the filing

In connection with Mr. Weaver’s resignation, the Company has appointed Heather Rees, age 51, as the Company’s principal financial and accounting officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Greg Weaver resigned as member of the Board of Directors at ATOSSA THERAPEUTICS, INC..

Action: resigned
Role: member of the Board of Directors

Exact text from the filing

Mr. Weaver’s termination of service as an employee served as his resignation from all other positions with the Company, including as a member of the Board of Directors.

View on SEC.gov

ATOSSA THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001437749-23-027849

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.